Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer

BACKGROUND: Solute Carrier Family 6 Member 1 (SLC6A1) has been identified as a cancer-promoting gene in various human cancers, such as clear cell renal cell carcinoma and ovarian cancer. However, its roles in prostate cancer (PCa) has not been fully elucidated. The aim of this study was to investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chaojiang, Cai, Zhiduan, Zhuo, Yangjia, Xi, Ming, Lin, Zhuoyuan, Jiang, Funeng, Liu, Zezhen, Wan, Yueping, Zheng, Yu, Li, Jianxin, Zhou, Xing, Zhu, Jianguo, Zhong, Weide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137497/
https://www.ncbi.nlm.nih.gov/pubmed/32252682
http://dx.doi.org/10.1186/s12885-020-06776-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137497/
https://www.ncbi.nlm.nih.gov/pubmed/32252682
http://dx.doi.org/10.1186/s12885-020-06776-7

Ejemplares similares